metabolic health

Moringa Cardiometabolic Randomized Trial Evidence Table

Structured evidence table for Moringa Cardiometabolic Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Moringa Cardiometabolic Randomized TrialA substantial portion of this global burden is attributable to modifiable metabolic risk factors, including increased fasting blood glucose (FBG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TAGs) [,,].1Crișan Diana (2025)Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
Moringa Cardiometabolic Randomized TrialThese metabolic risk factors are frequently accompanied by anthropometric changes (i.e., increased body weight [BW], body mass index [BMI], waist circumference [WC], and excess adiposity) and elevated blood pressure (systolic and diastolic) [,,].1Crișan Diana (2025)Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
Moringa Cardiometabolic Randomized TrialAccording to current clinical guidelines from organizations such as the American Heart Association and the International Diabetes Federation, these parameters are recognized as critical indicators of cardiometabolic risk, as they contribute to insulin resistance, endothelial dysfunction, and atherogenesis, key processes underlying the development of cardiometabolic diseases [,].1Crișan Diana (2025)Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
Moringa Cardiometabolic Randomized Trial1 2 3 4 5 6 7 8 9 Non-communicable diseases (NCDs) are the leading cause of death globally, accounting for approximately 75% of non-pandemic-related deaths globally, with cardiometabolic disorders, such as cardiovascular disease, type 2 diabetes, dyslipidemia, and hypertension, representing the most significant contributors [].1Crișan Diana (2025)Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
Moringa Cardiometabolic Randomized Trial9 10 9 Despite compelling preclinical evidence, antioxidant-based interventions have not translated consistently into clinical benefit.3Sezerano Marie Louise (2026)Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera
Moringa Cardiometabolic Randomized TrialThis narrative, integrative review addresses this gap through a mechanistically interpretive synthesis of evidence spanning in silico, in vitro, in vivo, and human clinical domains, contextualized against established pharmacological benchmarks, to define what current evidence justifies and what future clinical investigation requires.3Sezerano Marie Louise (2026)Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera
Moringa Cardiometabolic Randomized Trialoleifera Table 1 Evidence Tier Evidence Source Translational Relevance Tier I Clinical Evidence and Evidence Syntheses (RCTs, systematic reviews, meta-analyses) Provides human-level evidence regarding efficacy, safety, tolerability, and clinically relevant outcomes.3Sezerano Marie Louise (2026)Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera
Moringa Cardiometabolic Randomized Trialoleifera 11 12–14 15 16 13 17 3 18 Within this context,merits systematic reassessment.3Sezerano Marie Louise (2026)Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera
topicMoringa Cardiometabolic Randomized Trial
claimA substantial portion of this global burden is attributable to modifiable metabolic risk factors, including increased fasting blood glucose (FBG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TAGs) [,,].
evidence level1
citationCrișan Diana (2025)
sourceEffects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
topicMoringa Cardiometabolic Randomized Trial
claimThese metabolic risk factors are frequently accompanied by anthropometric changes (i.e., increased body weight [BW], body mass index [BMI], waist circumference [WC], and excess adiposity) and elevated blood pressure (systolic and diastolic) [,,].
evidence level1
citationCrișan Diana (2025)
sourceEffects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
topicMoringa Cardiometabolic Randomized Trial
claimAccording to current clinical guidelines from organizations such as the American Heart Association and the International Diabetes Federation, these parameters are recognized as critical indicators of cardiometabolic risk, as they contribute to insulin resistance, endothelial dysfunction, and atherogenesis, key processes underlying the development of cardiometabolic diseases [,].
evidence level1
citationCrișan Diana (2025)
sourceEffects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
topicMoringa Cardiometabolic Randomized Trial
claim1 2 3 4 5 6 7 8 9 Non-communicable diseases (NCDs) are the leading cause of death globally, accounting for approximately 75% of non-pandemic-related deaths globally, with cardiometabolic disorders, such as cardiovascular disease, type 2 diabetes, dyslipidemia, and hypertension, representing the most significant contributors [].
evidence level1
citationCrișan Diana (2025)
sourceEffects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
topicMoringa Cardiometabolic Randomized Trial
claim9 10 9 Despite compelling preclinical evidence, antioxidant-based interventions have not translated consistently into clinical benefit.
evidence level3
citationSezerano Marie Louise (2026)
sourceBeyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera
topicMoringa Cardiometabolic Randomized Trial
claimThis narrative, integrative review addresses this gap through a mechanistically interpretive synthesis of evidence spanning in silico, in vitro, in vivo, and human clinical domains, contextualized against established pharmacological benchmarks, to define what current evidence justifies and what future clinical investigation requires.
evidence level3
citationSezerano Marie Louise (2026)
sourceBeyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera
topicMoringa Cardiometabolic Randomized Trial
claimoleifera Table 1 Evidence Tier Evidence Source Translational Relevance Tier I Clinical Evidence and Evidence Syntheses (RCTs, systematic reviews, meta-analyses) Provides human-level evidence regarding efficacy, safety, tolerability, and clinically relevant outcomes.
evidence level3
citationSezerano Marie Louise (2026)
sourceBeyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera
topicMoringa Cardiometabolic Randomized Trial
claimoleifera 11 12–14 15 16 13 17 3 18 Within this context,merits systematic reassessment.
evidence level3
citationSezerano Marie Louise (2026)
sourceBeyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera

Learn next

Related evidence and supplement guides

GuideLion's Mane Mushroom: What the Evidence Actually Shows for Brain HealthLegacy library material — check the original sources.GuideNMN and NR: What the Nicotinamide Adenine Dinucleotide Supplements Actually PromiseLegacy library material — check the original sources.GuideCoQ10 (Ubiquinol vs Ubiquinone): Who Benefits and What the Evidence ShowsLegacy library material — check the original sources.GuideCollagen Supplements: What They Can and Cannot Do for Skin and JointsLegacy library material — check the original sources.AnswerWhat does the evidence say about Moringa Cardiometabolic Randomized Trial?Legacy library material — check the original sources.AnswerWhat does the evidence say about Alpha-Lipoic Acid Cardiometabolic Markers Randomized Trial?Legacy library material — check the original sources.AnswerWhat does the evidence say about Green Tea Extract Cardiometabolic Markers Randomized Trial?Legacy library material — check the original sources.AnswerWhat does the evidence say about Chlorella Cardiometabolic Markers Randomized Trial?Legacy library material — check the original sources.

Source documents

  1. Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
  2. Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera